← All patents

US9856233B2

Therapeutics targeting truncated adenomatous polyposis coli (APC) proteins

University of Texas System

Abstract

The described invention provides small molecule anti-cancer compounds that selectively target and inhibit measurable biological activity of truncated APC proteins, an immortalized Human Colonic Epithelial Cell (HCEC) model, and pharmaceutical compositions comprising at least one of the small …

University
University of Texas System
Assignee
Board Of Regents Of The University Of Texas System
Inventor
Jef De Brabander
Priority date
September 10, 2013
Filing date
September 10, 2014
Grant date
January 02, 2018
Publication date
January 02, 2018
Language
en
Metadata fetched
August 29, 2026 00:25